Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study.

Bavendiek U, Berliner D, Dávila LA, Schwab J, Maier L, Philipp SA, Rieth A, Westenfeld R, Piorkowski C, Weber K, Hänselmann A, Oldhafer M, Schallhorn S, von der Leyen H, Schröder C, Veltmann C, Störk S, Böhm M, Koch A, Bauersachs J; DIGIT-HF Investigators and Committees (see Appendix).

Eur J Heart Fail. 2019 May;21(5):676-684. doi: 10.1002/ejhf.1452. Epub 2019 Mar 20.

PMID:
30892806
2.

Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS).

Johnen A, Bürkner PC, Landmeyer NC, Ambrosius B, Calabrese P, Motte J, Hessler N, Antony G, König IR, Klotz L, Hoshi MM, Aly L, Groppa S, Luessi F, Paul F, Tackenberg B, Bergh FT, Kümpfel T, Tumani H, Stangel M, Weber F, Bayas A, Wildemann B, Heesen C, Zettl UK, Zipp F, Hemmer B, Meuth SG, Gold R, Wiendl H, Salmen A; German Competence Network Multiple Sclerosis (KKNMS).

J Neurol. 2019 Feb;266(2):386-397. doi: 10.1007/s00415-018-9142-y. Epub 2018 Dec 4.

3.

Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury-induced inflammation and fibrosis.

Thorenz A, Derlin K, Schröder C, Dressler L, Vijayan V, Pradhan P, Immenschuh S, Jörns A, Echtermeyer F, Herzog C, Chen R, Rong S, Bräsen JH, van Kooten C, Kirsch T, Klemann C, Meier M, Klos A, Haller H, Hensen B, Gueler F.

Kidney Int. 2018 Oct;94(4):741-755. doi: 10.1016/j.kint.2018.04.005. Epub 2018 Jun 21.

PMID:
29935951
4.

Cardiac pacemaker channel (HCN4) inhibition and atrial arrhythmogenesis after releasing cardiac sympathetic activation.

Chobanyan-Jürgens K, Heusser K, Duncker D, Veltmann C, May M, Mehling H, Luft FC, Schröder C, Jordan J, Tank J.

Sci Rep. 2018 May 17;8(1):7748. doi: 10.1038/s41598-018-26099-9.

5.

Somatic Development in Children with Congenital Heart Defects.

Poryo M, Paes LA, Pickardt T, Bauer UMM, Meyer S, Wagenpfeil S, Abdul-Khaliq H; German Competence Network for Congenital Heart Defects Investigators.

J Pediatr. 2018 Jan;192:136-143.e4. doi: 10.1016/j.jpeds.2017.09.059.

PMID:
29246335
6.

Implementation of an IT-guided checklist to improve the quality of medication history records at hospital admission.

Huber T, Brinkmann F, Lim S, Schröder C, Stekhoven DJ, Marti WR, Egger RR.

Int J Clin Pharm. 2017 Dec;39(6):1312-1319. doi: 10.1007/s11096-017-0545-0. Epub 2017 Oct 29.

7.

Assessing soil biodiversity potentials in Europe.

Aksoy E, Louwagie G, Gardi C, Gregor M, Schröder C, Löhnertz M.

Sci Total Environ. 2017 Jul 1;589:236-249. doi: 10.1016/j.scitotenv.2017.02.173. Epub 2017 Mar 2.

PMID:
28262359
8.

Protein Profiling Gastric Cancer and Neighboring Control Tissues Using High-Content Antibody Microarrays.

Sill M, Schröder C, Shen Y, Marzoq A, Komel R, Hoheisel JD, Nienhüser H, Schmidt T, Kastelic D.

Microarrays (Basel). 2016 Jul 8;5(3). pii: E19. doi: 10.3390/microarrays5030019.

9.

Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.

Bakdash G, Buschow SI, Gorris MA, Halilovic A, Hato SV, Sköld AE, Schreibelt G, Sittig SP, Torensma R, Duiveman-de Boer T, Schröder C, Smits EL, Figdor CG, de Vries IJ.

Cancer Res. 2016 Aug 1;76(15):4332-46. doi: 10.1158/0008-5472.CAN-15-1695. Epub 2016 Jun 20.

10.

Correction: Classifiers for Ischemic Stroke Lesion Segmentation: A Comparison Study.

Maier O, Schröder C, Forkert ND, Martinetz T, Handels H.

PLoS One. 2016 Feb 12;11(2):e0149828. doi: 10.1371/journal.pone.0149828. eCollection 2016. No abstract available.

11.

Utilisation of antibody microarrays for the selection of specific and informative antibodies from recombinant library binders of unknown quality.

Kibat J, Schirrmann T, Knape MJ, Helmsing S, Meier D, Hust M, Schröder C, Bertinetti D, Winter G, Pardes K, Funk M, Vala A, Giese N, Herberg FW, Dübel S, Hoheisel JD.

N Biotechnol. 2016 Sep 25;33(5 Pt A):574-81. doi: 10.1016/j.nbt.2015.12.003. Epub 2015 Dec 17.

12.

Criterion definition for the identification of physical-geographical boundaries of Khorezm oasis through remotely sensed data.

Matchanov M, Teodoro A, Schroder C.

Environ Monit Assess. 2016 Jan;188(1):35. doi: 10.1007/s10661-015-5035-z. Epub 2015 Dec 16.

PMID:
26676411
13.

Classifiers for Ischemic Stroke Lesion Segmentation: A Comparison Study.

Maier O, Schröder C, Forkert ND, Martinetz T, Handels H.

PLoS One. 2015 Dec 16;10(12):e0145118. doi: 10.1371/journal.pone.0145118. eCollection 2015. Erratum in: PLoS One. 2016;11(2):e0149828.

14.

Definition of a serum marker panel for glioblastoma discrimination and identification of Interleukin 1β in the microglial secretome as a novel mediator of endothelial cell survival induced by C-reactive protein.

Nijaguna MB, Schröder C, Patil V, Shwetha SD, Hegde AS, Chandramouli BA, Arivazhagan A, Santosh V, Hoheisel JD, Somasundaram K.

J Proteomics. 2015 Oct 14;128:251-61. doi: 10.1016/j.jprot.2015.07.026. Epub 2015 Jul 29.

PMID:
26232108
15.

Clinical proteomics: promises, challenges and limitations of affinity arrays.

Betzen C, Alhamdani MS, Lueong S, Schröder C, Stang A, Hoheisel JD.

Proteomics Clin Appl. 2015 Apr;9(3-4):342-7. doi: 10.1002/prca.201400156. Epub 2015 Mar 2. Review.

17.

Prediction of recurrence of non muscle-invasive bladder cancer by means of a protein signature identified by antibody microarray analyses.

Srinivasan H, Allory Y, Sill M, Vordos D, Alhamdani MS, Radvanyi F, Hoheisel JD, Schröder C.

Proteomics. 2014 Jun;14(11):1333-42. doi: 10.1002/pmic.201300320. Epub 2014 Apr 29.

PMID:
24610664
18.

Plasma protein analysis of patients with different B-cell lymphomas using high-content antibody microarrays.

Schröder C, Srinivasan H, Sill M, Linseisen J, Fellenberg K, Becker N, Nieters A, Hoheisel JD.

Proteomics Clin Appl. 2013 Dec;7(11-12):802-12. doi: 10.1002/prca.201300048.

PMID:
24323458
19.

Affinity-based microarrays for proteomic analysis of cancer tissues.

Hoheisel JD, Alhamdani MS, Schröder C.

Proteomics Clin Appl. 2013 Jan;7(1-2):8-15. doi: 10.1002/prca.201200114. Review.

PMID:
23341233
20.

Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines.

Alhamdani MS, Youns M, Buchholz M, Gress TM, Beckers MC, Maréchal D, Bauer A, Schröder C, Hoheisel JD.

J Proteomics. 2012 Jun 27;75(12):3747-59. doi: 10.1016/j.jprot.2012.04.042. Epub 2012 May 9.

PMID:
22579748

Supplemental Content

Loading ...
Support Center